ACTIVE ANKYLOSING SPONDYLITIS
Clinical trials for ACTIVE ANKYLOSING SPONDYLITIS explained in plain language.
Never miss a new study
Get alerted when new ACTIVE ANKYLOSING SPONDYLITIS trials appear
Sign up with your email to follow new studies for ACTIVE ANKYLOSING SPONDYLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could ease stiff spine pain for thousands
Disease control Recruiting nowThis study tests a new tablet called VC005 for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 420 adults aged 18 to 70 will take the drug or a placebo for 12 weeks to see if it reduces symptoms by at least 20%. The goal i…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Phase: PHASE3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated May 26, 2026 09:07 UTC
-
Real-World check: arthritis drug xeljanz XR under safety watch in korea
Disease control Recruiting nowThis study is a post-marketing surveillance required by Korean regulators to monitor the safety and effectiveness of Xeljanz XR (tofacitinib) in everyday medical practice. It will enroll about 200 adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, or ankylo…
Matched conditions: ACTIVE ANKYLOSING SPONDYLITIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:51 UTC